CD4+ T cell senescence is associated with reduced reactogenicity in severe/critical COVID-19
Jie Zhang,Chun Chang,Zhaoyuan Liang,Tingting Hu,Zhongnan Yin,Ying Liang,Ting Zhang,Yanling Ding,Xianlong Li,Xiaoyan Gai,Xiaoxue Yang,Xin Li,Xixuan Dong,Jiaqi Ren,Yafei Rao,Jun Wang,Jianling Yang,Lixiang Xue,Yongchang Sun
DOI: https://doi.org/10.1101/2023.08.04.551565
2023-01-01
Abstract:Background Aging is a critical risk factor for unfavorable clinical outcomes among COVID-19 patients and may affect vaccine efficacy. However, whether the senescence of T cells impact the progression to severe COVID-19 in the elderly individuals remains unclear.
Methods By using flow cytometry, we analyzed the frequency of senescent T cells (Tsens) in the peripheral blood from 100 elderly patients hospitalized for COVID-19 and compared the difference between mild/moderate and severe/critical illness. We also assessed correlations between the percentage of Tsens and the quantity and quality of spike-specific antibodies by ELISA, neutralizing antibody test kit and Elispot assay respectively, cytokine production profile of COVID-19 reactive T cells as well as plasma soluble factors by cytometric bead array (CBA).
Results We found a significant elevated level of CD4+ Tsens in severe/critical disease compared to mild/moderate illness and patients with a higher level of CD4+ Tsens (>19.78%) showed a decreased survival rate as compared to those with a lower level (<19.78%), especially in the breakthrough infection. The percentage of CD4+ Tsens was negatively correlated with spike-specific antibody titers, neutralization ability and COVID-19 reactive IL-2+ CD4+ T cells. Additionally, IL-2 producing T cells and plasma levels of IL-2 were positively correlated with antibody levels.
Conclusion Our data illustrated that the percentage of CD4+ Tsens in the peripheral blood could act as an efficient biomarker for the capacity of spike-specific antibody production and the prognosis of severe COVID-19, especially in the breakthrough infection. Therefore, restoration of the immune response of CD4+ Tsens is one of the key factors to prevent severe illness and improve vaccine efficacy in older adults.
### Competing Interest Statement
The authors have declared no competing interest.
* ACE
: angiotensin converting enzyme
BMI
: body mass index
CD
: cluster of differentiation
COVID
: corona virus disease
CBA
: cytometric bead array
CRP
: C-reactive protein
CM
: central memory
COPD
: chronic obstructive pulmonary disease
CXCL
: C-X-C motif ligand
CCL
: C-C motif ligand
DC
: dendritic cells
ELISA
: enzyme-linked immunosorbent assay
Elispot
: enzyme-linked immunoblot
EM
: effector memory
EMRA
: terminally differentiated effector cells
EDTA
: ethylene diamine tetraacetic acid
IL
: interleukin
ICU
: intensive care unit
IgG
: immunoglobulin G
IgM
: immunoglobulin M
IFN-γ
: interferon-γ
LDH
: lactate dehydrogenase
PCT
: procalcitonin
PLT
: platelet
PBMCs
: peripheral blood mononuclear cells
RBD
: receptor binding domain
RBC
: red blood cell
RR
: respiratory rate
SARS-CoV-2
: severe acute respiratory syndrome coronavirus 2
SASP
: senescent associated secretory phenotype
Tsens
: senescent T cells
TNF-α
: tumor necrosis factor
Th
: helper T cells
WT
: wild type
What problem does this paper attempt to address?